Cargando…

Case report of apatinib mesylate treatment in rare advanced tracheal adenoid cystic carcinoma

A 57‐year‐old man was admitted to our department 10 years ago, diagnosed with tracheal adenoid cystic carcinoma. After discontinuing chemotherapy and radiotherapy, the disease recurred in December 2016. Apatinib mesylate (500 mg/day) was administered and computed tomography revealed that his symptom...

Descripción completa

Detalles Bibliográficos
Autor principal: Wang, Hongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668510/
https://www.ncbi.nlm.nih.gov/pubmed/28892250
http://dx.doi.org/10.1111/1759-7714.12506